Semarion raises $3.8M to scale cell assay technology

Semarion, a University ofCambridge spin-out from the Cavendish Laboratory, has raised $3.8 million (£2.9million) in funding to support the expansion of its cell-based screeningtechnology. The round wa…

Bioniq cashes in on personalised health boom with $150M Herbalife acquisition

Bioniq, creator of personalised supplements based on blood biomarker analysis, has entered into an agreement for the sale of its assets to global nutrition company Herbalife. Founded in 2019, Bioniq d…

Parallel raises $20M to scale AI solutions for hospital administration

Paris-based Parallel, a startup developing AI agents forhospitals, has raised $20 million in a Series A round led by Index Ventures,with participation from Frst, Y Combinator, Hexa, and several angel …

Health Lean Analytics secures over €2.1M to automate hospital data and optimise surgical workflows

Barcelona-based startup Health Lean Analytics (HLA) has raised €2.1 million funding, encompassing a €1.4 million seed financing round by several family offices— including Inderhabs, Namarel and Brain…

CiaoDott raises €1.5M pre-seed to bring vertical voice AI to Italy’s medical sector

CiaoDott a vertical voice AI for the Italian medical sector, has raised €1.5 million Pre-Seed. The Techshop led the funding round, with Vento, Club degli Investitori, Growth Engine, and Alpha Venture…

Mental health startup Bliss raises $270K to build culturally intelligent AI for therapy

Originallyfounded in Albania and headquartered in Finland, mental health startup Blisshas raised $270,000 in angel funding led by Keiretsu Forum, Finest Love VC, andPlug and Play to develop AI infrast…

Bootstrapped to €500M: the story behind Kilo’s quiet rise — and its next billion-dollar bet

As consumer health shifts toward longevity, quantified wellness and personalised nutrition, one of Europe’s fastest-growing health tech companies is repositioning itself for the next wave. Founded in …

Antiverse secures $9.3M Series A for AI antibody platform

UK-based Antiverse, abiotech company developing AI-designed therapeutic antibodies forhard-to-target disease targets, has closed a $9.3 million Series A round led bySoulmates Ventures, with participat…

Qura secures €1.5M to rethink health management in Europe

Milan-based Qura, an AI-powered full-stackhealth platform, has closed a €1.5 million pre-seed round led by United Ventures, with participation from Vento, Italian Angels for Growth (IAG) andseveral in…